Repotrectinib, a next generation TRK inhibitor, overcomes TRK resistance mutations including solvent front, gatekeeper and compound mutations Meeting Abstract
| Authors: | Drilon, A.; Zhai, D.; Deng, W.; Zhang, X.; Lee, D.; Rogers, E.; Whitten, J.; Huang, Z.; Graber, A.; Liu, J.; Stopatschinskaja, S.; Cui, J. J.; Kim, D. W.; Cho, B. C.; Doebele, R. C.; Ou, S. H. I.; Lee, J.; Shaw, A. T. |
| Abstract Title: | Repotrectinib, a next generation TRK inhibitor, overcomes TRK resistance mutations including solvent front, gatekeeper and compound mutations |
| Meeting Title: | 110th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 79 |
| Issue: | 13 Suppl. |
| Meeting Dates: | 2019 Mar 29-Apr 3 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2019-07-01 |
| Language: | English |
| ACCESSION: | WOS:000488129902109 |
| DOI: | 10.1158/1538-7445.Am2019-442 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 442 -- Source: Wos |
